Skip to content
AlternativeMed

Herbs & Botanicals · Herbs · Velvet bean, natural L-DOPA source, small trials, safety first

Mucuna Pruriens

Mucuna pruriens (L.) DC. · also called Velvet bean, kapikacchu, cowhage

Mucuna pruriens is a tropical bean plant. Its seeds naturally contain levodopa (L-DOPA), the main Parkinson's medicine. Small trials in people with Parkinson's found movement benefit similar to levodopa, but the plant is a drug-strength source and has caused serious harm when overused.

General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made

Get your Mucuna Pruriens today. Order now from Amazon and have it delivered to your door.Shop Mucuna Pruriens on AmazonSupport our free guides: as an Amazon Associate we earn from qualifying purchases.

About Mucuna Pruriens

Mucuna pruriens (velvet bean) is a tropical legume whose seeds contain levodopa (L-DOPA), a drug used to treat Parkinson's. A few small trials in people with Parkinson's found that roasted seed powder worked about as well as levodopa medicines, but long-term safety is not known and the neurologists who ran the trials say it should stay within trials or specialist care. Fertility and stress claims rest on uncontrolled studies. Products vary hugely in levodopa content, and overuse and raw seeds have caused serious harm.

What it is

Mucuna pruriens (L.) DC. is a plant in the legume family (Fabaceae). The seeds are the part used. The pods are covered with hairs that cause intense itching on contact.

Seed levodopa has been measured at between 0.58% and 6.42% of dry weight in one study of 56 seed samples. Serotonin and mucunain are often mentioned, but we could not confirm them in the sources we read.

9 22 14

What the research shows

The best human research is in Parkinson's disease: five small trials (108 people) reviewed in 2025, three rated low quality. Single doses of seed powder gave faster or longer 'on' time than levodopa tablets, but a 16-week pilot saw half of people stop for stomach upset or worse movement, and a 12-month open-label trial in Ghana (32 people) found similar outcomes to levodopa with more side effects (not statistically different).

For male fertility, three uncontrolled studies from one Indian group report better sperm count and hormones. They had no placebo group. Mood and blood sugar results come from animals only.

10 5 6 1 26 16 15

A food-like plant that acts like a drug

Reviewers describe Mucuna as a potent dopaminergic therapy needing the same caution as levodopa medicines. Overuse has caused dyskinesia, psychosis and dopamine dysregulation, where a person cannot stop taking more.

Product amounts are unpredictable: levodopa ranged from 6% to 141% of the label in six products, and 2 to 241 mg per serving in 16 US products.

7 28 29 8

At a glance

Traditional uses history, not proof

  • Parkinson's-like illness in Ayurveda (called Kampavata, per a product-quality paper)
  • Male tonic and aphrodisiac (widely repeated; not verified in a historical source)

Studied for research

  • Parkinson's disease movement symptoms, low certainty (small trials, 108 people in a 2025 review)
  • Faster or longer 'on' time versus levodopa, low (single-dose studies)
  • Male fertility and testosterone, very low (uncontrolled studies)
  • Stress in infertile men, very low (no placebo)
  • Mood and blood sugar: animal studies only

Main compounds

  • Levodopa (L-DOPA, CID 6047), the main active chemical
  • Serotonin and 5-HTP: not verified in the seed
  • Hairs on pods cause itching

Common forms

  • Roasted seed powder (used in trials)
  • Capsule or extract supplements (levodopa content varies from 6% to 141% of label in one test)
  • Raw seeds (can poison)

Research links: Systematic review of Mucuna trials in Parkinson's (2025) · Advice review: To Bean or Not to Bean (2026) · Levodopa content of US supplements (JAMA Neurology 2022) · Research Library · Genes & Biomarkers Library

The plant and its history

Accepted scientific name
Mucuna pruriens (L.) DC. (velvet bean)
Naming authority
(L.) DC., as returned by the GBIF Backbone (usageKey 2951499).
Common names
Velvet bean (English); Kapikacchu (Sanskrit/Hindi (supplied name; not verified in a source read)); Cowhage / cowitch (English (used in the nutrient-graph notes; not verified in a source read))
Botanical family
Fabaceae (legume / pea family).
Classification
Plantae > Tracheophyta > Magnoliopsida > Fabales > Fabaceae > Mucuna > Mucuna pruriens
Native range
Described as growing in tropical areas worldwide in the trial papers; not verified further.
Habitat
Not verified.
What the plant looks like
Roots: Not described in sources read.; Stems: Not described.; Leaves: Not described.; Flowers: Not described.; Fruit: A pod with hairs that cause itching; the seeds are the part used (Reunion case; trials).
Cultivation
Not verified.
Harvest and processing
Trials used roasted, ground seeds. Raw seeds are linked to poisoning. A 2024 guidance paper covers how to grow, store and supply Mucuna for trials.
Look-alikes and adulterants
Name: Other Mucuna varieties; Note: Four varieties were compared in one study (var. pruriens, hirsuta, utilis, thekkadiensis); levodopa content differed between them.
Sustainability and conservation
Not verified.

Traditional use and history history, not clinical proof

Tradition or eraDocumented useSource
Ayurvedic medicine, IndiaSeed powder used for 'Kampavata', now understood to be Parkinson's disease (as stated in a paper on product quality).p28922612
Aphrodisiac and male tonic useWidely repeated; NOT verified from a historical source.p18001713

Traditional use shows how a plant was used. It does not show that a supplement works or is safe today.

What is inside, and how it may work

What the plant contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.

Main compounds

CompoundFamilyWhere it is concentratedActivity studiedLevel of evidence
Levodopa (L-dopa)
PubChem 6047
amino acid, dopamine precursorSeed
0.58% to 6.42% of seed dry weight across 56 accessions; 4.02% in the Japanese seed powder used in a trial; 4 to 6% stated in the 2025 review
Converted to dopamine in the brain; the basis of the Parkinson's effect and many of the side effects. 22 25 10 19Human data
Serotonin
PubChem 5202
monoamineNot verified
Not verified
Listed among compounds of interest in the request and in unreferenced nutrient-graph notes; no source read confirms its presence in the seed. NOT verified. 20Laboratory research
5-Hydroxytryptophan (5-HTP) and tryptamines
PubChem 144
serotonin precursorsSeed (possible)
Not verified
The 2026 clinic review says improper processing in a Mozambique outbreak may have produced serotonin-like alkaloids and neurotoxic metabolites, possibly including 5-HTP and tryptamines (secondary statement). 7 21Laboratory research
Mucunain (itch protein) in the hairsprotein/enzyme (reported)Hairs on pods and seeds
Not verified
The hairs cause intense itching on skin contact; the specific compound mucunain was not named in the abstracts read. NOT verified. 14 12Other

Mechanisms, receptors and pathways

Target or pathwayGene or receptorWhat was foundLevel
Dopamine replacementDopamine pathway (levodopa converted by DOPA decarboxylase)Levodopa from the seed is converted to dopamine. Without a decarboxylase inhibitor more is converted outside the brain, raising stomach and heart side effects. 7 4Human data
Higher drug exposureLevodopa blood levelIn 8 and 11 patients, Mucuna gave higher levodopa levels (AUC +165.3%, +55.67% above comparator); onset was faster in the first study. 11 2Human data
COMT inhibition (possible)COMTA lower 3-O-methyl-dopa/levodopa ratio after Mucuna in 7 patients suggested a COMT-inhibiting effect (authors' interpretation). 25Human data
Different brain firing patternsSubstantia nigra reticulata, subthalamic nucleusIn parkinsonian monkeys Mucuna did not increase the bursting firing seen with levodopa+carbidopa and a water extract eased parkinsonism without dyskinesia. 13Animal research
Semen and hormone effectsHypothalamus-pituitary-testis axis; dopamine, adrenaline, noradrenalineIn infertile men treatment raised testosterone, LH and the catecholamines and lowered FSH and prolactin (uncontrolled study). 26Human data
Antioxidant effects in semenSOD, catalase, glutathione, lipid peroxideMarkers moved towards normal in infertile men (uncontrolled). 27 1Human data
Blood glucose loweringNot definedSeed extract lowered glucose in diabetic rats. 15Animal research

Absorption, metabolism and elimination

Absorption
Single doses of seed powder gave faster and higher levodopa blood levels than a levodopa/carbidopa tablet in 8 people (peak +110%, AUC +165.3%) and than a levodopa/benserazide tablet in 11 people (AUC ratio 155.67%). Tmax and half-life were similar in the second study.
Distribution
No data found.
Metabolism
Without a decarboxylase inhibitor, more levodopa is converted outside the brain. A COMT-inhibiting effect was suggested in 7 patients.
Elimination
Half-life was similar to the levodopa tablet in the 11-person study.
Bioavailability
Varies with product; levodopa content differs widely between products and seeds.

11 2 25 7 30

Isolated compounds versus whole extracts

Trials used whole roasted seed powder. A 2017 trial found high-dose Mucuna similar to levodopa alone at the same dose, with a more favourable tolerability profile, and a monkey study suggests a water extract may act differently from levodopa. Whether other seed compounds matter in people is unproven.

Nutritional composition

The seed is a food legume in some countries (a review calls it a natural food legume), but it needs proper preparation. It is not a normal dietary source of nutrients and raw seeds are unsafe.

11benefits and uses looked at
30studies and sources checked
Low certaintybest evidence rating found
10lab markers tracked in trials

1 mixed findings3 low certainty4 very low certainty3 not enough evidence

What was looked at

The 11 benefits and uses checked for Mucuna Pruriens, each with how strong the evidence is. Tap one to open it.

Lab markers tracked in the studies

Parkinson's motor scores (UPDRS and similar)Time in the 'on' stateLevodopa blood level (AUC)Dyskinesia ratingSerum cortisolSperm count (concentration)Sperm motilityTestosterone and LHSeminal lipid peroxideBlood glucose (rats)

What is Mucuna Pruriens good for?

The studied uses and how strong the human evidence is. 'Low' and 'very low' mean small or weak studies. 'Insufficient' means no human trial. Safety comes first: see the Safety tab.

Parkinson's disease: movement symptomsLow certaintyA 2025 review of 5 trials (108 people, three low quality) found symptom benefit similar to levodopa. Trials used roasted seed powder, mostly single doses. Not shown to slow the disease. Faster and longer 'on' timeLow certaintyIn four single-dose studies of 7 to 18 people, Mucuna started sooner or kept people moving longer than levodopa tablets, with higher levodopa blood levels. Dyskinesia (uncontrolled movements)Mixed findingsSingle-dose trials found no extra dyskinesia. But overuse of a supplement caused dyskinesia and dopamine dysregulation in a case report. Tolerability in Parkinson'sLow certaintyHalf of 14 people stopped Mucuna in a 16-week pilot, mostly for stomach upset. A single case report found adding carbidopa helped. Semen quality in infertile menVery low certaintyThree uncontrolled studies from one Indian group report better sperm count and motility. No placebo group. Testosterone and hormonesVery low certaintyOne uncontrolled study of 75 infertile men reported higher testosterone and LH and lower FSH and prolactin. Stress in infertile menVery low certaintyOne uncontrolled study of 60 men reported less stress after 3 months of seed powder; no placebo. Antioxidant markers in semenVery low certaintyLipid peroxide fell and antioxidants rose in infertile men; marker results only. Low mood and depressionNot enough evidenceNo human trial. Animal studies only; Mucuna can also cause psychosis and hallucinations. Blood sugarNot enough evidenceA rat study showed glucose falls. No human trial. Be careful with diabetes medicine. Sexual desireNot enough evidenceSold as an aphrodisiac, but no human trial was found.

Benefits, one by one

Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.

Parkinson's disease: movement symptoms

Low certainty

Small trials in people with Parkinson's found that Mucuna seed powder eased movement symptoms about as well as levodopa medicines. The evidence is limited and the plant is a drug-strength source of levodopa, so this is not a casual supplement use.

10 studiesTrials used roasted seed powder, not supplements. Product levodopa co…

Studies, doses and limits

What the trials found

A 2025 systematic review found 5 trials with 108 people in total; three were rated low quality. Single-dose crossover trials (Katzenschlager 2004, 8 people; Cilia 2017, 18 people; Hasshou 2024, 7 people; Thai trial 2025, 11 analysed) found motor benefit similar to or longer than levodopa. A 16-week crossover pilot (14 people) found similar benefit in those who tolerated it, but half stopped. A 12-month open-label trial in 32 untreated people in Ghana found similar outcomes to levodopa plus a decarboxylase inhibitor. Neurologists who ran the trials advise use only in trials or under neurologist plans.

Results

Most trials show symptom benefit comparable to levodopa medicines, in small groups and mostly with single doses.

Effect sizes as reported

Review: 5 trials, 108 people; no pooled estimate. Individual trials: see the 'on' time and tolerability entries.

Why this rating

Several small trials agree, but the reviewers rate three of five trials low quality, most are single-dose, some are open-label or single-blind, and long-term data are scarce.

Form and dose studied

Trials used roasted seed powder, not supplements. Product levodopa content varies widely (see the Safety tab).

Who was studied

Adults with Parkinson's, mostly advanced disease or treatment-free in low-income settings.

Limits

Small numbers, short follow-up, mostly single doses, different preparations. No evidence in the trials read that it slows the disease.

Why researchers looked

Mucuna seed naturally contains levodopa, the main Parkinson's medicine. Levodopa is turned into dopamine in the brain.

Traditional use

Kampavata, an Ayurvedic illness now understood to be Parkinson's disease, is named in a paper on product quality (Soumyanath 2018). Other traditional claims were not verified.

Proposed mechanism Animal research

Levodopa from the seed is converted to dopamine. Whether other seed compounds add anything is unproven. In monkeys, a water extract eased parkinsonism without dyskinesia, which hints at a different action from levodopa alone (animal result).

A proposed mechanism does not show that the effect happens in people.

Mucuna seed is a natural source of levodopa, a strong drug. It needs the same caution as levodopa medicines. Overuse has caused dyskinesia, dopamine dysregulation syndrome and psychosis. Use only with a neurologist.

10 11 4 5 2 6 25 7 3 13

Parkinson's: faster and longer 'on' time

Low certainty

In single-dose studies, Mucuna powder started working sooner or kept people moving well for longer than a levodopa tablet. Blood levels of levodopa were also higher, which is part of why strength and side effects both matter.

5 studiesSingle doses of roasted seed powder or a seed preparation.

Studies, doses and limits

What the trials found

Katzenschlager 2004: with 30 g mucuna, onset of effect was 34.6 vs 68.5 min and 'on' time was 21.9% (37 min) longer than levodopa/carbidopa. Thai 2025: 'on' time without dyskinesia was 232.2 vs 161.8 min (p = 0.01) with higher drug exposure (AUC ratio 155.67%). Hasshou 2024: 'on' time prolonged about 2-fold in 7 people. Cilia 2017: high dose gave longer 'on' time than levodopa plus benserazide.

Results

Longer 'on' time in four small single-dose crossover studies.

Effect sizes as reported

Katzenschlager: 21.9% longer 'on' time, p = 0.021. Thai trial: 232.2 vs 161.8 min, p = 0.01; AUC ratio 155.67% (90% CI 134.59-180.04).

Why this rating

Consistent direction but each study had 7 to 18 people, single doses, short follow-up, and different comparators.

Form and dose studied

Single doses of roasted seed powder or a seed preparation.

Who was studied

People with Parkinson's with motor complications.

Limits

Single-dose, tiny numbers. A higher drug level can also mean more side effects. The Thai trial was single-blind.

Why researchers looked

'On' time is the time when Parkinson's medicine is working and movement is good.

Traditional use

Kampavata, an Ayurvedic illness now understood to be Parkinson's disease, is named in a paper on product quality (Soumyanath 2018). Other traditional claims were not verified.

Proposed mechanism Pharmacological theory

Higher and faster levodopa blood levels from the seed powder; one small study suggested a COMT-inhibiting effect from a metabolite ratio (inference).

A proposed mechanism does not show that the effect happens in people.

Mucuna seed is a natural source of levodopa, a strong drug. It needs the same caution as levodopa medicines. Overuse has caused dyskinesia, dopamine dysregulation syndrome and psychosis. Use only with a neurologist.

11 2 25 4 10

Dyskinesia (uncontrolled movements)

Mixed findings

In single-dose trials, Mucuna did not cause more dyskinesia than levodopa, and sometimes less. But in real-world self-treatment and a 16-week trial, overuse and poor tolerability were serious problems. This is a double-edged topic.

8 studiesRoasted seed powder in trials vs commercial capsules in the case repo…

Studies, doses and limits

What the trials found

Single-dose trials: no significant difference in dyskinesias (Katzenschlager 2004), fewer dyskinesias (Cilia 2017), no increase (Hasshou 2024, Thai 2025). The 2025 review reported no dyskinesia in its five trials. Against this, a case report describes dyskinesias and dopamine dysregulation after long overuse of a supplement, and a 2026 clinic review links overuse to dyskinesia.

Results

No extra dyskinesia in single-dose trials; real-world overuse has caused it.

Why this rating

Trials point one way (not worse) while case reports and clinical experience point the other.

Form and dose studied

Roasted seed powder in trials vs commercial capsules in the case report.

Who was studied

People with Parkinson's.

Limits

Single doses cannot show what happens with years of use. Self-dosing is unmonitored.

Why researchers looked

Long-term levodopa can cause dyskinesia. Early reports suggested Mucuna might cause less.

Traditional use

Kampavata, an Ayurvedic illness now understood to be Parkinson's disease, is named in a paper on product quality (Soumyanath 2018). Other traditional claims were not verified.

Proposed mechanism Animal research

Monkey study: water extract eased parkinsonism without drug-induced dyskinesia, with different brain firing patterns than levodopa+carbidopa.

A proposed mechanism does not show that the effect happens in people.

Do not self-adjust doses; stop and call your neurologist if movements worsen.

11 4 25 2 10 28 7 13

Parkinson's: tolerability and adding carbidopa

Low certainty

Nausea and stomach upset are common with Mucuna powder. Half of people in one 16-week trial stopped it. One case report found that adding carbidopa helped. This is a safety and tolerability topic, not a benefit claim.

5 studiesPowder from roasted seed; supernatant water in the extension.

Studies, doses and limits

What the trials found

Cilia 2018: 7 of 14 (50%) stopped Mucuna (4 stomach side effects, 3 worsening motor performance); dropouts then tolerated a 'supernatant water' preparation. Africa 2026: adverse events 56% vs 37.5% (p = 0.48), 12.5% stopped. Thai 2025: more mild nausea and dizziness with Mucuna. Radder 2019: carbidopa added to Mucuna in one woman gave marked motor improvement.

Results

Frequent stomach upset; tolerability limits long-term use.

Effect sizes as reported

Dropout 7 of 14 in the pilot; adverse events 56% vs 37.5% (not significant).

Why this rating

Small trials and a single case report.

Form and dose studied

Powder from roasted seed; supernatant water in the extension.

Who was studied

People with Parkinson's.

Limits

Case report is one person; do not add carbidopa on your own.

Why researchers looked

Without a drug that blocks early breakdown of levodopa (a decarboxylase inhibitor), more levodopa is converted outside the brain, which raises stomach and heart side effects.

Traditional use

Kampavata, an Ayurvedic illness now understood to be Parkinson's disease, is named in a paper on product quality (Soumyanath 2018). Other traditional claims were not verified.

Proposed mechanism Pharmacological theory

Mucuna is normally taken without a decarboxylase inhibitor, so more peripheral conversion of levodopa occurs (stated in the 2026 clinic review).

A proposed mechanism does not show that the effect happens in people.

Combining Mucuna with carbidopa or other Parkinson's drugs is a medical decision.

5 6 2 23 7

Stress in men with infertility

Very low certainty

One uncontrolled study in 60 stressed infertile men found lower stress and lower seminal oxidative damage after 3 months of Mucuna seed powder. There was no placebo group, so this cannot show the plant did it.

1 studiesSeed powder, 5 g per day, 3 months (Shukla 2010).

Studies, doses and limits

What the trials found

Shukla 2010: 60 infertile men with psychological stress (questionnaire and raised serum cortisol) and 60 healthy fertile controls. After 3 months of 5 g/day seed powder, stress and seminal lipid peroxide were significantly reduced and sperm count and motility improved. Numbers were not in the abstract.

Results

Reported improvement in stress, no placebo.

Effect sizes as reported

Statistically significant improvements reported; exact values not in the abstract.

Why this rating

Single uncontrolled before-after study, no blinding described, same research group as other fertility studies; funding not stated in the abstract.

Form and dose studied

Seed powder, 5 g per day, 3 months (Shukla 2010).

Who was studied

Infertile Indian men with stress.

Limits

No placebo; controls were healthy men, not a comparison for treatment.

Why researchers looked

Stress can lower semen quality; Mucuna has been proposed to help through dopamine and antioxidant effects.

Traditional use

Kampavata, an Ayurvedic illness now understood to be Parkinson's disease, is named in a paper on product quality (Soumyanath 2018). Other traditional claims were not verified.

Proposed mechanism Preliminary mechanism

Proposed dopamine and antioxidant effects; not shown in this study design.

A proposed mechanism does not show that the effect happens in people.

Mucuna's dopamine effects can also cause mood changes (see Safety tab).

27

Low mood and depression

Not enough evidence

No human trial of Mucuna for depression was found. Animal studies suggest antidepressant-like effects, but they cannot show what happens in people. Mucuna can also cause psychiatric side effects.

2 studiesNot applicable.

Studies, doses and limits

What the trials found

A 2024 review collected animal studies and states that clinical trials are needed. No human trial of mood was identified in the sources read.

Results

Animal evidence only.

Why this rating

No human trial; animal evidence cannot be transferred.

Limits

Animal-only evidence.

Why researchers looked

Mucuna raises dopamine through levodopa, and dopamine is involved in mood.

Traditional use

Kampavata, an Ayurvedic illness now understood to be Parkinson's disease, is named in a paper on product quality (Soumyanath 2018). Other traditional claims were not verified.

Proposed mechanism Animal research

Animal models show effects on dopamine, serotonin, noradrenaline, oxidative stress and inflammation.

A proposed mechanism does not show that the effect happens in people.

Psychosis, hallucinations and dopamine dysregulation have been reported with Mucuna levodopa supplements.

16 28

Semen quality in men with infertility

Very low certainty

Three studies from one Indian group report better sperm count and movement in infertile men after Mucuna seed powder. None used a placebo group, so the result is very uncertain.

4 studiesSeed powder; 5 g/day for 3 months in one study.

Studies, doses and limits

What the trials found

Ahmad 2008: 60 infertile men vs 60 healthy controls; sperm concentration and motility rose, with partial recovery in men with low motility. Shukla 2009: 75 infertile men vs 75 controls; sperm count and motility 'significantly recovered'. Shukla 2010: 60 stressed infertile men, 5 g/day for 3 months; sperm count and motility improved. A 2021 systematic review of 20 herbal RCTs (1,519 men) includes Mucuna among eleven treatments and reported benefit in all but one study, but its abstract does not separate Mucuna results.

Results

Improved sperm count and motility reported; no placebo-controlled data read.

Effect sizes as reported

Statistically significant improvements; actual values not in the abstracts.

Why this rating

Before-after designs without placebo, no blinding described, same research group, doses and funding not stated in two abstracts. Pregnancy outcomes were not reported in the abstracts.

Form and dose studied

Seed powder; 5 g/day for 3 months in one study.

Who was studied

Indian men attending infertility screening.

Limits

Three uncontrolled before-after studies from the same Lucknow, India research group; controls were healthy fertile men, not placebo. Doses not given in two abstracts.

Why researchers looked

Mucuna is used in Ayurveda as a male tonic. Seminal oxidative damage and hormone changes were proposed as reasons it could help.

Traditional use

Aphrodisiac and male tonic uses are widely repeated; no historical source was read, so treat as NOT verified.

Proposed mechanism Preliminary mechanism

Reported changes in dopamine, adrenaline, noradrenaline and antioxidant markers in semen and blood.

A proposed mechanism does not show that the effect happens in people.

Mucuna acts on dopamine; see the Safety tab. No safety outcomes were reported in the fertility abstracts.

1 26 27 24

Testosterone and reproductive hormones

Very low certainty

One study reported higher testosterone and LH and lower FSH and prolactin in infertile men after Mucuna. It had no placebo group and is the only human hormone data found.

1 studiesSeed powder.

Studies, doses and limits

What the trials found

Shukla 2009: in 75 infertile men, treatment significantly improved testosterone, LH and levels of dopamine, adrenaline and noradrenaline, and reduced FSH and prolactin.

Results

Hormone levels moved in the 'healthy' direction.

Effect sizes as reported

Statistically significant; numbers not in the abstract.

Why this rating

Single uncontrolled before-after study.

Form and dose studied

Seed powder.

Who was studied

Infertile Indian men.

Limits

No placebo, no blinding described; hormone changes are not the same as better health or fertility.

Why researchers looked

Dopamine can influence the hormones that control the testes.

Traditional use

Not verified.

Proposed mechanism Preliminary mechanism

Dopamine from levodopa is thought to act through the hypothalamus-pituitary-testis axis (stated by the authors; not proven here).

A proposed mechanism does not show that the effect happens in people.

Raised testosterone from Mucuna has not been shown in healthy men.

26

Antioxidant markers in semen

Very low certainty

In infertile men, lipid peroxide (a marker of oxidative damage) fell and antioxidant vitamins and enzymes rose after Mucuna powder. This is a lab-marker result, not a health outcome.

2 studiesSeed powder.

Studies, doses and limits

What the trials found

Ahmad 2008: lipid peroxidation fell; lipids, vitamins A, C and E recovered. Shukla 2010: lipid peroxide fell and SOD, catalase, glutathione and ascorbic acid were restored.

Results

Marker changes reported.

Effect sizes as reported

Statistically significant; no numbers in the abstracts.

Why this rating

Marker changes only; no placebo.

Form and dose studied

Seed powder.

Who was studied

Infertile men.

Limits

Uncontrolled; markers only.

Why researchers looked

Oxidative stress in semen is linked to poor sperm quality.

Traditional use

Not verified.

Proposed mechanism Preliminary mechanism

Antioxidant effects of seed compounds, per the authors.

A proposed mechanism does not show that the effect happens in people.

None noted.

1 27

Blood sugar

Not enough evidence

No human trial of Mucuna for blood sugar was found. A rat study showed large glucose falls with a seed extract. Because of this, anyone on diabetes medicine should be careful.

1 studiesNone.

Studies, doses and limits

What the trials found

No human trial found. Rat study: blood glucose fell 18.6% to 55.4% across doses at 8 hours; glibenclamide 59.7%.

Results

Animal evidence only.

Effect sizes as reported

Rats: glucose fell 18.6% to 55.4% (5 to 100 mg/kg).

Why this rating

Animal evidence only.

Limits

Rodent model; doses not comparable to people.

Why researchers looked

Traditional use in diabetes is often repeated but was not verified in a source read.

Traditional use

Not verified.

Proposed mechanism Animal research

Extract lowered glucose in alloxan-induced diabetic rats.

A proposed mechanism does not show that the effect happens in people.

Possible added effect with diabetes medicines is theory only (no human data).

15

Sexual desire and aphrodisiac use

Not enough evidence

Mucuna is widely sold as an aphrodisiac. No human trial of libido or sexual function was found in the sources read.

1 studiesNone.

Studies, doses and limits

What the trials found

No human trial identified. The fertility studies above measured semen and hormones, not desire.

Results

No human data.

Why this rating

No trials.

Limits

No trials.

Why researchers looked

Marketed as a sex-drive herb because of its dopamine effect.

Traditional use

Aphrodisiac use is widespread but was not verified from a historical source.

Proposed mechanism Pharmacological theory

Dopamine is involved in sexual desire (theory).

A proposed mechanism does not show that the effect happens in people.

Dopaminergic drugs can cause impulse-control problems such as hypersexuality (levodopa drug label).

30

Connections to the rest of health

How Mucuna Pruriens connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.

Explore every connection: goals, body systems, organs, symptoms, genes

A. Wellness goals

Connected toKind of connectionEvidence statusContextStudies
Brain Health Demonstrated clinical effect Low certainty Parkinson's disease: movement symptoms: Small trials in people with Parkinson's found that Mucuna seed powder eased movement symptoms about as well as levodopa medicines. The evidence is limited and the plant is a drug-strength source of levodopa, so this is not a casual supplement use. Parkinson's: faster and longer 'on' time: In single-dose studies, Mucuna powder started working sooner or kept people moving well for longer than a levodopa tablet. Blood levels of levodopa were also higher, which is part of why strength and side effects both matter. 10 11 4 5 2 6 25 7 3 13 28
Brain Health Adverse effect or risk Low certainty Parkinson's: tolerability and adding carbidopa: Nausea and stomach upset are common with Mucuna powder. Half of people in one 16-week trial stopped it. One case report found that adding carbidopa helped. This is a safety and tolerability topic, not a benefit claim. 5 6 2 23 7
Stress Reduction Potential benefit Very low certainty Stress in men with infertility: One uncontrolled study in 60 stressed infertile men found lower stress and lower seminal oxidative damage after 3 months of Mucuna seed powder. There was no placebo group, so this cannot show the plant did it. 27
Mens Vitality Potential benefit Very low certainty Stress in men with infertility: One uncontrolled study in 60 stressed infertile men found lower stress and lower seminal oxidative damage after 3 months of Mucuna seed powder. There was no placebo group, so this cannot show the plant did it. Semen quality in men with infertility: Three studies from one Indian group report better sperm count and movement in infertile men after Mucuna seed powder. None used a placebo group, so the result is very uncertain. 27 1 26 24
Mood Balance Preliminary mechanism Not enough evidence Low mood and depression: No human trial of Mucuna for depression was found. Animal studies suggest antidepressant-like effects, but they cannot show what happens in people. Mucuna can also cause psychiatric side effects. 16 28
Fertility Support Potential benefit Very low certainty Semen quality in men with infertility: Three studies from one Indian group report better sperm count and movement in infertile men after Mucuna seed powder. None used a placebo group, so the result is very uncertain. 1 26 27 24
Hormone Balance Potential benefit Very low certainty Testosterone and reproductive hormones: One study reported higher testosterone and LH and lower FSH and prolactin in infertile men after Mucuna. It had no placebo group and is the only human hormone data found. 26
Fertility Support Biological association Very low certainty Antioxidant markers in semen: In infertile men, lipid peroxide (a marker of oxidative damage) fell and antioxidant vitamins and enzymes rose after Mucuna powder. This is a lab-marker result, not a health outcome. 1 27
Blood Sugar Balance Preliminary mechanism Not enough evidence Blood sugar: No human trial of Mucuna for blood sugar was found. A rat study showed large glucose falls with a seed extract. Because of this, anyone on diabetes medicine should be careful. 15
Libido Support Traditional use Not enough evidence Sexual desire and aphrodisiac use: Mucuna is widely sold as an aphrodisiac. No human trial of libido or sexual function was found in the sources read. 30
Mens Vitality Traditional use Not enough evidence Sexual desire and aphrodisiac use: Mucuna is widely sold as an aphrodisiac. No human trial of libido or sexual function was found in the sources read. 30

B. Body systems

Connected toKind of connectionEvidence statusContextStudies
Nervous System Biological association Low certainty Studied for: Parkinson's disease: movement symptoms Studied for: Parkinson's: faster and longer 'on' time 10 11 4 5 2 6 25 7 3 13 28 23 16
Digestive System Biological association Low certainty Studied for: Parkinson's: tolerability and adding carbidopa 5 6 2 23 7
Stress Mood Biological association Very low certainty Studied for: Stress in men with infertility Studied for: Low mood and depression 27 16 28
Reproductive System Biological association Very low certainty Studied for: Stress in men with infertility Studied for: Semen quality in men with infertility 27 1 26 24 30
Endocrine System Biological association Very low certainty Studied for: Testosterone and reproductive hormones Studied for: Blood sugar 26 15

E. Health conditions

Connected toKind of connectionEvidence statusContextStudies
Melanoma Contraindication Low certainty Drug-label caution, inferred.
Preparation or compound: Mucuna seed
30 17
Dopamine dysregulation syndrome Adverse effect or risk Low certainty Case report.
Preparation or compound: Mucuna supplement
28
Pregnancy Contraindication Very low certainty Avoid; no data.
Preparation or compound: Mucuna seed
30
Parkinson's disease Demonstrated clinical effect Low certainty Small trials found benefit similar to levodopa; neurologist supervision needed.
Preparation or compound: Roasted seed powder
10 4
Male infertility Potential benefit Very low certainty Uncontrolled studies only.
Preparation or compound: Seed powder
1 26

I. Biomarkers

Connected toKind of connectionEvidence statusContextStudies
Parkinson's motor scores (UPDRS and similar) Biological association Low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 4 6 10
Time in the 'on' state Biological association Low certainty Measured in trials: raised. A lab change is not the same as a health benefit. 11 2 25
Levodopa blood level (AUC) Biological association Low certainty Measured in trials: raised. A lab change is not the same as a health benefit. 11 2
Dyskinesia rating Biological association Mixed findings Measured in trials: no-change. A lab change is not the same as a health benefit. 11 4 28
Serum cortisol Biological association Very low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 27
Sperm count (concentration) Biological association Very low certainty Measured in trials: raised. A lab change is not the same as a health benefit. 1 26 27
Sperm motility Biological association Very low certainty Measured in trials: raised. A lab change is not the same as a health benefit. 1 27
Testosterone and LH Biological association Very low certainty Measured in trials: raised. A lab change is not the same as a health benefit. 26
Seminal lipid peroxide Biological association Very low certainty Measured in trials: lowered. A lab change is not the same as a health benefit. 1 27
Blood glucose (rats) Biological association Not enough evidence Measured in trials: lowered. A lab change is not the same as a health benefit. 15

J. Genes, receptors and enzymes

Connected toKind of connectionEvidence statusContextStudies
COMT (catechol-O-methyltransferase) Preliminary mechanism Human A metabolite ratio suggested COMT inhibition. 25

K. Biological pathways

Connected toKind of connectionEvidence statusContextStudies
Dopamine synthesis and signalling Preliminary mechanism Human Levodopa from the seed feeds dopamine production. 7
Hypothalamus-pituitary-testis axis Preliminary mechanism Human Hormone changes in infertile men. 26

L. Active compounds

Connected toKind of connectionEvidence statusContextStudies
Levodopa (L-dopa) Biological association Human Converted to dopamine in the brain; the basis of the Parkinson's effect and many of the side effects.
Preparation or compound: Seed
22 25 10 19
Serotonin Biological association In vitro Listed among compounds of interest in the request and in unreferenced nutrient-graph notes; no source read confirms its presence in the seed. NOT verified.
Preparation or compound: Not verified
20
5-Hydroxytryptophan (5-HTP) and tryptamines Biological association In vitro The 2026 clinic review says improper processing in a Mozambique outbreak may have produced serotonin-like alkaloids and neurotoxic metabolites, possibly including 5-HTP and tryptamines (secondary statement).
Preparation or compound: Seed (possible)
7 21
Mucunain (itch protein) in the hairs Biological association Other The hairs cause intense itching on skin contact; the specific compound mucunain was not named in the abstracts read. NOT verified.
Preparation or compound: Hairs on pods and seeds
14 12

Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 25, 2026).

Evidence at a glance: what changed in 10 lab markers

Tap a number to show only those markers. Counts are markers, not people.

The evidence

The research centre for Mucuna Pruriens. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.

Evidence by outcome

Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).

How we rate evidence

High certainty

Several well-run trials or reviews agree; further research is unlikely to change the picture much.

Moderate certainty

Good trials point the same way, but some doubt remains.

Low certainty

Small, short or inconsistent trials. The finding could change with better research.

Very low certainty

Very little or very weak human data. Treat as a possibility only.

Mixed findings

Trials or reviews disagree with each other.

Not enough evidence

Not enough human research to say either way.

Evidence against

Good research found no benefit, or found harm.

We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We searched PubMed, read abstracts of the trials and reviews, and read two reviews and a case report in full. Statements about drug interactions come from levodopa drug labels and are marked as inference. Pages that could not be opened are marked not read.

Study library: every study we checked 30
StudyDesignPeopleProduct, dose, lengthResult
Ahmad 2008
Effect of Mucuna pruriens on semen profile and biochemical parameters in seminal plasma of infertile men
Fertil Steril · PMID 18001713 · DOI
Other
120
60 healthy fertile men (controls) and 60 men in infertility screening, India
Mucuna pruriens seed powder
seed powder Not given in abstract Not given in abstract · vs Healthy fertile men (not a placebo group)
Treatment inhibited lipid peroxidation and raised sperm concentration and motility in all infertile groups. Oligozoospermic men recovered sperm concentration; motility was not restored to normal in asthenozoospermic men. Seminal lipids, vitamins A, C and E recovered.
Statistically significant; numbers not in abstract
Methods, limits and funding

Outcomes: Semen profile, lipid peroxide, fructose, antioxidant vitamins

Limitations: Prospective before-after study with healthy-men comparison, no placebo. Dose not in abstract.

Read: abstract

Boonmongkol 2025
Comparative efficacy of Mucuna pruriens and conventional levodopa in Parkinson's disease: a randomized controlled trial on pharmacokinetics and clinical perspectives from Asia
J Neural Transm (Vienna) · PMID 40137945 · DOI
Controlled trial
12
12 people with Parkinson's and motor complications (11 analysed)
Mucuna powder vs levodopa/benserazide dispersible tablets
seed powder 30 g MP vs two 100/25 levodopa tablets Single sessions, two-week washout (crossover, single-blind) · vs Levodopa/benserazide 100/25 x2
MP gave higher exposure: geometric mean AUC 12,424.81 vs 7981.69 ng.h/mL; ratio 155.67%. Tmax and half-life were similar. 'On' time without dyskinesia 232.2 vs 161.8 min (p = 0.01). Mild, short-lived nausea and dizziness were more frequent with MP.
AUC ratio 155.67% (90% CI 134.59 to 180.04)
Methods, limits and funding

Outcomes: Blood levels (AUC, Cmax, Tmax, half-life), 'on' time, adverse events

Limitations: Eleven analysed, single-blind, single doses.

Read: abstract

Caronni 2024
Mucuna pruriens to treat Parkinson's disease in low-income countries: Recommendations and practical guidelines from the farmer to clinical trials
Parkinsonism Relat Disord · PMID 38797572 · DOI
Review
Expert review (authors who run the Mucuna trials) Mucuna pruriens
seed
MP could be an affordable alternative or add-on to levodopa where levodopa is hard to get; tolerability varies; caution until long-term data exist. Aim: more clinical trials before promoting individual use.
n/a
Methods, limits and funding

Outcomes: Practical recommendations

Limitations: Expert opinion from the group that ran the trials.

Funding and conflicts: One author is an associate editor of the journal (stated).

Read: abstract

Cilia 2017
Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study
Neurology · PMID 28679598 · DOI
Controlled trial
18
18 people with advanced Parkinson's
Roasted Mucuna seed powder (no pharmacological processing) vs dispersible levodopa/benserazide, levodopa alone, MP plus benserazide, placebo
seed powder (roasted) MP low 12.5 mg/kg; MP high 17.5 mg/kg; LD+DDCI 3.5 mg/kg Single doses (six-way crossover) · vs Levodopa+benserazide; levodopa alone; placebo
Low-dose MP gave similar motor response to LD+DDCI with fewer dyskinesias and adverse events. High-dose MP gave greater improvement at 90 and 180 min and longer 'on' time with fewer dyskinesias. High-dose MP had fewer adverse events than LD+DDCI and LD without DDCI. No differences in cardiovascular response.
Met all non-inferiority outcomes (single dose).
Methods, limits and funding

Outcomes: Motor response at 90 and 180 min, 'on' duration, adverse events, blood pressure, dyskinesias

Limitations: Single doses only, 18 people, advanced disease. Abstract-level reading.

Registration: NCT02680977

Read: abstract

Cilia 2018
Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study
Parkinsonism Relat Disord · PMID 29352722 · DOI
Controlled trial
14
14 people with Parkinson's with motor fluctuations and dyskinesias
Mucuna powder from roasted seeds vs levodopa/carbidopa
seed powder (roasted) Not given in abstract 16 weeks (crossover) · vs Levodopa/carbidopa
Seven of 14 (50%) stopped Mucuna early: 4 for gastrointestinal side effects and 3 for worsening motor performance. No one stopped during the levodopa/carbidopa phase. In those who tolerated Mucuna, response was similar to levodopa/carbidopa. Dropouts moved to Mucuna 'supernatant water' (median 16 weeks), which was well tolerated.
Half stopped Mucuna early.
Methods, limits and funding

Outcomes: Quality of life, motor and non-motor symptoms, tolerability, adverse events

Limitations: Pilot, 14 people; tolerability problems limited the result.

Registration: NCT02680977

Read: abstract

Cilia 2026
Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial
J Parkinsons Dis · PMID 41269916 · DOI
Controlled trial
32
32 people with untreated Parkinson's disease in Ghana
Mucuna powder from roasted seeds vs levodopa plus decarboxylase inhibitor
seed powder (roasted) Weight- and stage-adjusted; not given in abstract 12 months (open-label) · vs Levodopa + DDCI
MP improved quality of life, motor and non-motor symptoms over 12 months with outcomes similar to levodopa + DDCI. Adverse events were more frequent with MP (56% vs 37.5%, p = 0.48). Most were mild; 12.5% led to stopping.
Similar outcomes; adverse events 56% vs 37.5% (not significant)
Methods, limits and funding

Outcomes: Quality of life, motor and non-motor symptoms, adverse events

Limitations: Open-label, 32 people, phase 2. Authors call for larger double-blind trials.

Funding and conflicts: No conflicts declared.

Registration: PACTR201611001882367

Read: abstract

Cilia 2026
"To Bean or Not to Bean": Therein lie the hype and the hope. Advice to people with Parkinson in my clinic about Mucuna pruriens
J Parkinsons Dis · PMID 42053204 · DOI
Review
Clinic advice review (Parkinson's neurologists) Mucuna pruriens
seed
Properly processed MP gave symptom benefits comparable to commercial levodopa in trials; long-term safety data scarce. MP is a potent dopaminergic therapy needing the same caution as levodopa drugs. Overuse linked to dyskinesia, dopamine dysregulation syndrome and psychiatric problems; toxicity from improper seed preparation reported. Use should stay in trials or neurologist-led plans. Full text also notes common adverse events (nausea, dizziness, somnolence), highly variable product levodopa, and that MP is not formally approved or registered for Parkinson's by regulators such as FDA or EMA.
n/a
Methods, limits and funding

Outcomes: Safety and advice

Limitations: Narrative expert review by authors of the main trials.

Funding and conflicts: No conflicts declared.

Read: full-text

Cohen 2022
Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database
JAMA Neurol · PMID 35939305 · DOI
Other
16
16 US Mucuna pruriens supplements listed in the NIH Dietary Supplement Label Database (of 20 identified)
Mucuna pruriens supplements (laboratory analysis)
seed (products)
Levodopa was found in 15 of 16 products, from 2 mg to 241 mg per recommended serving. The paper warns that the levodopa may unpredictably complicate management of Parkinson's and other diseases.
Range 2 to 241 mg per serving
Methods, limits and funding

Outcomes: Levodopa amount per recommended serving

Limitations: One sample per brand; batch variation unknown. Read in the full text.

Funding and conflicts: Author Cohen reports grants from The Pew Charitable Trusts and Consumers Union and a civil suit with a supplement company (outside this work).

Read: full-text

GBIF 2026
GBIF Backbone: Mucuna pruriens (L.) DC. (usageKey 2951499)
GBIF · Source
Other
in-vitro

unspecified
Accepted species, exact match, confidence 99; family Fabaceae; order Fabales.
Methods, limits and funding

Read: full-text

Hammoud 2025
Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials
Parkinsons Dis · PMID 40860042 · DOI
Systematic review
108
People with Parkinson's disease; 5 clinical trials, mean age 60
Mucuna pruriens (various preparations) compared with levodopa
seed (various) Varied between trials Varied · vs Levodopa
466 articles found; 5 trials (108 people) included. Quality: one high, one some concerns, three low. Findings consistently showed better symptoms and fewer therapy complications: shorter time to 'on', longer 'on' time, fewer adverse events, no dyskinesia reported.
Narrative synthesis, no pooled estimate. Authors: promising but evidence limited.
Methods, limits and funding

Outcomes: Parkinson's symptoms, time in the 'on' state, adverse events

Limitations: Five small trials, three rated low quality, different preparations, narrative synthesis only.

Funding and conflicts: No conflicts declared.

Read: abstract

Katzenschlager 2004
Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
J Neurol Neurosurg Psychiatry · PMID 15548480 · DOI
Controlled trial
8
8 people with Parkinson's with short levodopa response and 'on' dyskinesias
Mucuna seed powder preparation vs levodopa/carbidopa (single doses)
seed powder 15 g and 30 g mucuna preparation vs 200/50 mg LD/CD Single doses at weekly intervals (crossover) · vs Levodopa/carbidopa 200/50 mg
30 g mucuna: faster onset (34.6 vs 68.5 min, p = 0.021); 'on' time 21.9% (37 min) longer (p = 0.021); peak levodopa blood level 110% higher; area under curve 165.3% larger (p = 0.012). No significant difference in dyskinesias or tolerability.
See results.
Methods, limits and funding

Outcomes: Motor scores, 'on' time, levodopa blood levels, dyskinesias

Limitations: Eight people, single doses, 4 hours of follow-up. Authors call for a longer controlled study.

Read: abstract

Lang-Illievich 2024
The effect of photobiomodulation on histamine and Mucuna pruriens-induced pruritus, hyperknesis and alloknesis in healthy volunteers: A double-blind, randomized, sham-controlled study
PLoS One · PMID 39024251 · DOI
Controlled trial
17
17 healthy volunteers
Mucuna pruriens applied to the skin as an itch model
hair/spicule (skin test) Single session · vs Sham light treatment
Mucuna was used to induce itch in healthy volunteers. Low-level light did not reduce Mucuna-induced itch (itch difference 0.8, 95% CI -2.3 to 3.8, p = 0.61).
No effect of light on Mucuna-induced itch (-2.3 to 3.8)
Methods, limits and funding

Outcomes: Itch intensity

Limitations: The trial tests a light treatment, not Mucuna. It shows Mucuna on skin is used as a research itch trigger.

Funding and conflicts: No competing interests declared.

Read: abstract

Lieu 2012
The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate
Evid Based Complement Alternat Med · PMID 22997535 · DOI
Animal research
animal
Parkinsonian monkeys Mucuna pruriens endocarp powder (with and without carbidopa) and a water extract
seed endocarp · vs Levodopa + carbidopa
Each treatment eased parkinsonism. Levodopa+carbidopa increased bursting firing in one brain area; Mucuna did not. A water extract eased parkinsonism without drug-induced dyskinesias, suggesting a mechanism different from levodopa alone.
Animal result
Methods, limits and funding

Outcomes: Parkinsonism, dyskinesia, neuron firing in the basal ganglia

Limitations: Monkey study; cannot be assumed for people.

Read: abstract

Maillot 2022
Poisoning After Ingestion of Mucuna pruriens Seeds on Reunion Island
Wilderness Environ Med · PMID 34895813 · DOI
Case report
1
58-year-old woman, Reunion Island
Five raw Mucuna pruriens seeds
raw seed 5 raw seeds Single ingestion
About 40 min after eating the seeds: nausea, vomiting, abundant diarrhoea, then confusion, hallucinations and amnesia. Vitals normal on arrival; only nausea lingered. The authors note the plant is also known for intense itching from contact with the hair on the beans.
Poisoning
Methods, limits and funding

Outcomes: Symptoms

Limitations: One case; she ate the seeds after reading articles on the internet.

Read: abstract

Majekodunmi 2011
Evaluation of the anti-diabetic properties of Mucuna pruriens seed extract
Asian Pac J Trop Med · PMID 21914541 · DOI
Animal research
animal
Alloxan-induced diabetic rats and mice Crude ethanolic extract of Mucuna seeds
seed 5 to 100 mg/kg in rats 8 hours; chronic dosing · vs Glibenclamide 5 mg/kg/day
Blood glucose fell 18.6% to 55.4% across doses at 8 h (glibenclamide 59.7%). Adverse reactions were seen at higher doses (8 to 32 mg/kg) in the mouse toxicity test; no deaths.
Animal result
Methods, limits and funding

Outcomes: Blood glucose

Limitations: Rats and mice only; no human data.

Read: abstract

Mata-Bermudez 2024
Mucuna pruriens, a Possible Treatment for Depressive Disorders
Neurol Int · PMID 39585071 · DOI
Review
animal
Animal models of depression (review) Mucuna pruriens
unspecified
Review of animal evidence for antidepressant-like effects (dopamine, serotonin, noradrenaline, oxidative stress, inflammation). The authors state clinical trials are needed.
n/a
Methods, limits and funding

Outcomes: Antidepressant-like effects in animals

Limitations: Animal evidence only; no human trial.

Funding and conflicts: No conflicts declared.

Read: abstract

MedlinePlus (US National Library of Medicine) 2024
Carbidopa and Levodopa (patient drug information)
MedlinePlus (US National Library of Medicine) · Source
Authoritative guidance

unspecified
Drug information for levodopa/carbidopa medicines, not Mucuna. Tells patients to report MAO inhibitors (phenelzine, selegiline, tranylcypromine) taken now or in the past two weeks; to report melanoma or an undiagnosed skin growth; to report pregnancy or breastfeeding; says the drug has caused hallucinations, psychosis and impulse control disorders. Diabetes appears in the list of conditions to tell the doctor about.
Methods, limits and funding

Read: full-text

NCCIH 2026
NCCIH: no Mucuna pruriens page (HTTP 404 at /health/mucuna-pruriens)
NCCIH · Source
Authoritative guidance

unspecified
Page not found when opened on 2026-10-25; no NCCIH Mucuna statement was read.
Methods, limits and funding

Read: summary-only

PubChem 2026
PubChem: Levodopa (CID 6047)
PubChem · Source
Other
in-vitro

unspecified
CID 6047, formula C9H11NO4, title Levodopa.
Methods, limits and funding

Read: summary-only

PubChem 2026
PubChem: Serotonin (CID 5202)
PubChem · Source
Other
in-vitro

unspecified
CID 5202, formula C10H12N2O, title Serotonin.
Methods, limits and funding

Read: summary-only

PubChem 2026
PubChem: 5-Hydroxytryptophan (CID 144)
PubChem · Source
Other
in-vitro

unspecified
CID 144, formula C11H12N2O3, title (+-)-5-Hydroxytryptophan.
Methods, limits and funding

Read: summary-only

Pulikkalpura 2015
Levodopa in Mucuna pruriens and its degradation
Sci Rep · PMID 26058043 · DOI
Other
in-vitro
56
56 seed accessions of four Mucuna pruriens varieties (laboratory)
Mucuna pruriens seeds (laboratory)
seed
L-dopa varied from 0.58% to 6.42% of dry weight. On repeated extraction an average of 52.11% of L-dopa degraded in the lab test.
0.58% to 6.42% dry weight
Methods, limits and funding

Outcomes: L-dopa content and breakdown

Limitations: Laboratory study; the degradation finding is from an extraction test, not from people.

Read: abstract

Radder 2019
Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report
J Parkinsons Dis · PMID 30856121 · DOI
Case report
1
48-year-old woman with Parkinson's
Carbidopa added to Mucuna pruriens
unspecified Not given in abstract Not given in abstract
Adding carbidopa to Mucuna gave marked motor improvement.
Single case.
Methods, limits and funding

Outcomes: Motor scores (MDS-UPDRS, video)

Limitations: One person; no control.

Read: abstract

Roozbeh 2021
A Systematic Review on Use of Medicinal Plants for Male Infertility Treatment
J Family Reprod Health · PMID 34721595 · DOI
Systematic review
1519
20 RCTs, 1519 men, eleven herbal treatments including Mucuna pruriens
Several plants (Mucuna pruriens is one of them)
various · vs Placebo
All studies except one reported benefit for sperm and reproductive parameters. The abstract does not separate out Mucuna results.
n/a
Methods, limits and funding

Outcomes: Sperm and reproductive parameters

Limitations: Plant-by-plant results not in abstract; further trials and side-effect data requested by authors.

Read: abstract

Sakata 2024
Japanese Mucuna pruriens (Hasshou Beans) Showed Fast-acting and Long-lasting Effects in Parkinson's Disease
Intern Med · PMID 38462520 · DOI
Other
7
7 people with Parkinson's
Roasted Mucuna seed powder (4.02% levodopa) vs levodopa/carbidopa
seed powder (roasted) 11 g MP vs 100/10 mg LD/CD Single doses (crossover) · vs Levodopa/carbidopa 100/10 mg
MP prolonged 'on' time 2-fold compared with LD/CD. Levodopa levels were higher after MP, with no increase in dyskinesia. The metabolite ratio suggested a COMT-inhibiting effect of MP.
'On' time about 2-fold
Methods, limits and funding

Outcomes: 'On' time, levodopa levels, metabolites, dyskinesia

Limitations: Seven people, single dose, crossover; the COMT idea is an inference from a metabolite ratio.

Funding and conflicts: No conflicts declared.

Read: abstract

Shukla 2009
Mucuna pruriens improves male fertility by its action on the hypothalamus-pituitary-gonadal axis
Fertil Steril · PMID 18973898 · DOI
Other
150
75 healthy fertile men (controls) and 75 men in infertility screening, India
Mucuna pruriens seed powder (dose not in abstract)
seed powder Not given in abstract Not given in abstract · vs Healthy fertile men (not a placebo group)
Treatment significantly improved testosterone, LH, dopamine, adrenaline and noradrenaline and lowered FSH and prolactin in infertile men. Sperm count and motility were significantly recovered.
Statistically significant; numbers not in abstract
Methods, limits and funding

Outcomes: Testosterone, LH, FSH, prolactin, seminal and blood dopamine/adrenaline/noradrenaline, sperm count and motility

Limitations: Prospective before-after study; the control group is healthy men, not placebo. No blinding described. Same research group as two other studies.

Read: abstract

Shukla 2010
Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men
Evid Based Complement Alternat Med · PMID 18955292 · DOI
Other
120
60 infertile men with psychological stress (questionnaire and raised serum cortisol) and 60 healthy fertile controls, India
Mucuna pruriens seed powder
seed powder 5 g per day 3 months · vs Healthy fertile men (not a placebo group)
Stressed infertile men had low sperm count and motility, high cortisol and lipid peroxide. After 3 months, stress and lipid peroxide were significantly reduced and sperm count and motility improved. Antioxidant markers (SOD, catalase, glutathione, ascorbic acid) were restored.
Statistically significant; numbers not in abstract
Methods, limits and funding

Outcomes: Stress, serum cortisol, semen quality, seminal oxidative markers

Limitations: Before-after study, no placebo group, no blinding described. Same group as other fertility studies.

Read: abstract

Sohutskay 2024
Dopamine Dysregulation Syndrome Presenting as Overuse of Mucuna pruriens Levodopa Supplement
J Mov Disord · PMID 38768952 · DOI
Case report
1
Woman with Parkinson's disease since age 47
Commercial Mucuna pruriens supplement bought online
seed (product) 3 to 5 capsules about every 3 hours, later about 100 capsules over 2 days From age 54 over several years
Brief hallucinations and paranoia, dyskinesias, vomiting and agitation, a psychotic episode, hiding medication and taking extra doses, attributed to dopamine dysregulation syndrome. Treatment switched to extended-release carbidopa/levodopa plus a rotigotine patch; she lacked insight; family arranged long-term care.
Serious harm in one patient
Methods, limits and funding

Outcomes: Psychiatric and motor complications

Limitations: Single case; she also used prescribed Parkinson's medicine. Read in the full text (PubMed has no abstract).

Funding and conflicts: No conflicts declared.

Read: full-text

Soumyanath 2018
Analysis of Levodopa Content in Commercial Mucuna pruriens Products Using High-Performance Liquid Chromatography with Fluorescence Detection
J Altern Complement Med · PMID 28922612 · DOI
Other
6
Six commercial Mucuna products
Mucuna pruriens products (laboratory analysis)
seed or extract (products) · vs Label claims
Levodopa ranged from 6% to 141% of label claims. No product was within the 90 to 110% pharmacopeial limits. Maximum daily levodopa delivered ranged from 14.4 to 720 mg/day. Certificates of analysis were inconsistent.
6% to 141% of label
Methods, limits and funding

Outcomes: Levodopa content versus label

Limitations: Six products only.

Funding and conflicts: No competing interests.

Read: abstract

UK electronic Medicines Compendium 2024
SINEMET 12.5 mg/50 mg Tablets: Summary of Product Characteristics (levodopa/carbidopa drug label)
UK electronic Medicines Compendium · Source
Authoritative guidance

unspecified
This is the label for a levodopa/carbidopa medicine, not for Mucuna. Used to show what levodopa drugs are known to do; applying it to Mucuna seed is an inference. Contraindications: non-selective MAO inhibitors; suspicious undiagnosed skin lesions or a history of melanoma; narrow-angle glaucoma; severe psychoses. Interactions: postural hypotension with antihypertensives; phenothiazines, butyrophenones and risperidone may reduce effect; iron salts reduce absorption; selegiline plus carbidopa-levodopa may cause severe orthostatic hypotension. Effects: dyskinesias; psychotic episodes with delusions, hallucinations; impulse control disorders. Pregnancy: levodopa and carbidopa-levodopa caused malformations in rabbits. Breast-feeding: carbidopa excretion into human milk unknown.
Methods, limits and funding

Read: full-text

What we do not know yet

  • No large placebo-controlled trial of Mucuna in Parkinson's.
  • No evidence that Mucuna slows Parkinson's disease.
  • No placebo-controlled trial for fertility, stress or testosterone.
  • No Mucuna-specific interaction, melanoma, liver or pregnancy data.
  • EMA/HMPC, LactMed, Commission E, WHO and LiverTox not found or not read; NCCIH has no page.
  • Serotonin and mucunain in the seed were not verified.

How new research is added

New studies are found by a saved PubMed search and placed in a review queue. A person reads each one before it changes any rating or safety wording.

Lab markers

What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".

Hormonal 2

▼

Serum cortisol

Lowered in trials

A stress hormone measured in blood.

Very low certainty
Results and what it means

Why it was measured

Used to define stress in the study.

Statistical vs. clinical meaning

No numbers in the abstract; no placebo group.

Safety implication

None noted.

StudyResultPeopleProduct
27Cortisol was raised at the start; the abstract reports stress improved but gives no cortisol numbers.60 stressed infertile men5 g/day seed powder, 3 months

27

▲

Testosterone and LH

Raised in trials

Male sex hormone and the pituitary hormone that drives it.

Very low certainty
Results and what it means

Why it was measured

Used to explain the mechanism.

Statistical vs. clinical meaning

Uncontrolled; no numbers in abstract.

Safety implication

None noted.

StudyResultPeopleProduct
26Testosterone and LH significantly improved; FSH and prolactin reduced.75 infertile menSeed powder

26

Metabolic 1

▼

Blood glucose (rats)

Lowered in trials

Sugar in the blood.

Not enough evidence
Results and what it means

Why it was measured

Tested in diabetic rats.

Statistical vs. clinical meaning

Animal only.

Safety implication

Possible additive effect with diabetes medicine is untested in people.

StudyResultPeopleProduct
15Glucose fell 18.6% to 55.4% across doses at 8 h.Alloxan-diabetic ratsEthanolic seed extract

15

Other 7

▼

Parkinson's motor scores (UPDRS and similar)

Lowered in trials

Standard rating scales of movement in Parkinson's disease.

Low certainty
Results and what it means

Why it was measured

Shows whether movement symptoms improved.

Statistical vs. clinical meaning

Clinically meaningful scales, but small groups and mostly single doses.

Safety implication

Dopaminergic drug effects; see Safety tab.

StudyResultPeopleProduct
4High-dose Mucuna gave greater motor improvement at 90 and 180 min than levodopa+benserazide (reported as met non-inferiority).18 people with advanced Parkinson'sRoasted seed powder, single dose
6Quality of life, motor and non-motor symptoms improved over 12 months, similar to levodopa+DDCI.32 untreated people, GhanaRoasted seed powder, 12 months

4 6 10

▲

Time in the 'on' state

Raised in trials

Time when Parkinson's medicine works and movement is good.

Low certainty
Results and what it means

Why it was measured

Directly relevant to daily function.

Statistical vs. clinical meaning

Consistent but tiny single-dose studies.

Safety implication

Higher blood levels may raise side effects.

StudyResultPeopleProduct
11'On' time 21.9% (37 min) longer with 30 g mucuna than levodopa/carbidopa (p = 0.021).8 peopleSingle dose
2'On' time without dyskinesia 232.2 vs 161.8 min (p = 0.01).11 analysed30 g powder vs levodopa/benserazide
25'On' time prolonged about 2-fold.7 people11 g powder vs 100/10 LD/CD

11 2 25

▲

Levodopa blood level (AUC)

Raised in trials

How much levodopa reaches the blood over time.

Low certainty
Results and what it means

Why it was measured

Shows drug exposure from the plant.

Statistical vs. clinical meaning

A drug-level measure, not a clinical benefit.

Safety implication

Higher exposure can mean more nausea, dizziness and other levodopa effects.

StudyResultPeopleProduct
11Peak levodopa 110% higher; AUC 165.3% larger vs levodopa/carbidopa (p = 0.012).8 people30 g mucuna preparation
2AUC geometric mean ratio 155.67% (90% CI 134.59-180.04); Tmax and half-life similar.11 analysed30 g powder

11 2

●

Dyskinesia rating

No clear change in trials

Rating of uncontrolled movements.

Mixed findings
Results and what it means

Why it was measured

Key safety outcome with levodopa.

Statistical vs. clinical meaning

Single-dose results vs real-world reports of dyskinesia from overuse.

Safety implication

Overuse can cause dyskinesia.

StudyResultPeopleProduct
11No significant difference in dyskinesias or tolerability.8 peopleSingle doses
4Fewer dyskinesias with low- and high-dose MP than levodopa+DDCI.18 peopleSingle dose

11 4 28

▲

Sperm count (concentration)

Raised in trials

Number of sperm per volume of semen.

Very low certainty
Results and what it means

Why it was measured

Main semen quality measure.

Statistical vs. clinical meaning

Before-after, no placebo.

Safety implication

None noted.

StudyResultPeopleProduct
1Sperm concentration increased in all infertile groups; oligozoospermic men recovered significantly.60 infertile menSeed powder
26Sperm count significantly recovered.75 infertile menSeed powder

1 26 27

▲

Sperm motility

Raised in trials

How well sperm move.

Very low certainty
Results and what it means

Why it was measured

Part of semen quality.

Statistical vs. clinical meaning

Before-after, no placebo.

Safety implication

None noted.

StudyResultPeopleProduct
1Motility improved but was not restored to normal in asthenozoospermic men.60 infertile menSeed powder
27Motility improved after 3 months.60 stressed infertile men5 g/day

1 27

▼

Seminal lipid peroxide

Lowered in trials

A marker of oxidative damage in semen.

Very low certainty
Results and what it means

Why it was measured

Marker of oxidative stress.

Statistical vs. clinical meaning

Marker only; uncontrolled.

Safety implication

None noted.

StudyResultPeopleProduct
1Lipid peroxidation inhibited.60 infertile menSeed powder
27Lipid peroxide reduced; SOD, catalase, glutathione, ascorbic acid restored.60 stressed infertile men5 g/day

1 27

Safety

What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.

Main points to know 8
  • Mucuna seed is a natural source of levodopa, a strong drug. Clinic neurologists who ran the Mucuna trials call it a potent dopaminergic therapy needing the same caution as levodopa medicines. They advise use only in clinical trials or neurologist-led plans until long-term safety is shown. Authoritative guidance 7 3
  • Overuse can cause dopamine dysregulation, psychosis and dyskinesia. A case report describes a woman with Parkinson's who took large amounts of a commercial Mucuna supplement and developed hallucinations, paranoia, dyskinesias and a psychotic episode, attributed to dopamine dysregulation syndrome. Case report 28 7
  • Levodopa content in products is unpredictable. Six commercial products held 6% to 141% of their label claim of levodopa (14.4 to 720 mg/day delivered). A US label-database analysis of 16 products found 2 to 241 mg per serving, and one had none. Other 29 8
  • Raw or poorly prepared seeds can poison. A woman who ate 5 raw seeds had nausea, vomiting, abundant diarrhoea, confusion, hallucinations and amnesia within about 40 minutes. Case report 14 7
  • Interactions with Parkinson's drugs, MAO inhibitors and other medicines. Levodopa medicines are contraindicated with non-selective MAO inhibitors, can lower blood pressure with blood pressure drugs, and are less effective with some antipsychotics. These facts come from levodopa drug labels and apply to Mucuna by inference; no Mucuna-specific interaction study was found. (Inference: this is a levodopa-medicine label, not a Mucuna source.) Pharmacological theory 30 17
  • Skin cancer caution (melanoma). Levodopa drug labels advise against use in people with a history of melanoma or suspicious undiagnosed skin lesions. No Mucuna-specific melanoma study was read; this is an inference from the drug label. Authoritative guidance 30 17
  • Pregnancy and breastfeeding: avoid. No Mucuna pregnancy or breastfeeding safety data were found. Levodopa and carbidopa-levodopa caused malformations in rabbits (drug label), and carbidopa passage into human milk is unknown. Authoritative guidance 30
  • Itching from hairs on raw pods. The hairs on the pods and beans are well known for causing intense itching on skin contact; Mucuna is used as a research itch trigger in volunteers. Case report 14 12
Side effects 8
EffectHow oftenSeverity and recoveryEvidence
Nausea, dizziness, sleepiness
More frequent with Mucuna than levodopa in the Thai trial; listed as common in trials by the 2026 clinic review.
Not given as a ratemild to moderate
Usually transient
Controlled trial 7 2
Stomach upset leading to stopping the powder
Seven of 14 stopped overall; 3 more for worsening motor performance.
4 of 14 stopped for stomach side effects in one trialmoderate
Not stated
Controlled trial 5
Adverse events overall
12.5% stopped because of them.
56% with Mucuna vs 37.5% with levodopa+DDCI over 12 months (not significant)mostly mild
Not stated
Controlled trial 6
Dyskinesia from overuse
Single-dose trials found no extra dyskinesia; overuse in practice has caused it.
No rate foundserious
Not stated
Case report 28 7
Hallucinations, paranoia, psychosis, dopamine dysregulation syndrome
Also after eating raw seeds.
No rate foundserious
Not stated
Case report 28 14
Low blood pressure on standing (theory)
Levodopa-drug label effect; no Mucuna-specific rate. (Inference: this is a levodopa-medicine label, not a Mucuna source.)
No rate foundunknown
Not stated
Pharmacological theory 30
Itching and skin irritation from pod hairs
Contact with the hairs, not eating the seed.
No rate foundmild to severe
Not stated
Case report 14 12
Impulse-control problems (gambling, hypersexuality, compulsive buying)
Levodopa-drug label effect. (Inference: this is a levodopa-medicine label, not a Mucuna source.)
No rate foundserious
Not stated
Pharmacological theory 30
Liver

No Mucuna liver injury report was found in the sources read. NIH LiverTox could not be opened (it showed a human-check page), so its assessment was not read. Not finding reports is not proof of safety. 7

How often. No frequency of human liver injury was found.

Monitoring. No agency monitoring advice was found.

This is a safety connection. It is not evidence that Mucuna Pruriens supports liver health.

Medicines and supplements 7
WithWhy it mattersImportanceEvidenceWhat to do
Levodopa, carbidopa, benserazide and other Parkinson's drugs (dopamine agonists, MAO-B and COMT inhibitors)
drug
Mucuna adds levodopa, so effects and side effects can add up. The 2026 clinic review says there is no clear guidance for combining Mucuna with these drugs or for reducing prescribed doses.Can cause too much dopamine effect: dyskinesia, nausea, psychosis.Authoritative guidance Low certainty 7 28Do not combine without your neurologist.
MAO inhibitors (phenelzine, tranylcypromine) and selegiline
drug
Non-selective MAO inhibitors are contraindicated with levodopa/carbidopa; selegiline plus carbidopa-levodopa may cause severe orthostatic hypotension.Possible dangerous blood pressure effects. (Inference: this is a levodopa-medicine label, not a Mucuna source.)Pharmacological theory Low certainty 30 17Do not combine unless a doctor directs it.
Antipsychotics (phenothiazines, butyrophenones, risperidone)
drug
These block dopamine D2 receptors and may reduce levodopa's effect. Levodopa can also worsen psychosis.Reduced effect; psychiatric risk. (Inference: this is a levodopa-medicine label, not a Mucuna source.)Pharmacological theory Low certainty 30Ask your prescriber.
Blood pressure medicines
drug
Postural hypotension can occur when levodopa/carbidopa is added to antihypertensives.Dizziness or fainting on standing. (Inference: this is a levodopa-medicine label, not a Mucuna source.)Pharmacological theory Low certainty 30Tell your doctor; blood pressure may need checking.
Diabetes medicines
drug
A rat study showed large glucose falls with a Mucuna extract. No human data. MedlinePlus lists diabetes as a condition to mention to doctors for levodopa.Possible additive blood-sugar lowering; unproven in people.Animal research Very low certainty 15 17Monitor sugar closely and tell your doctor.
Iron supplements
drug
Levodopa/carbidopa absorption falls with ferrous sulphate or gluconate (drug label).Possible weaker effect. (Inference: this is a levodopa-medicine label, not a Mucuna source.)Pharmacological theory Low certainty 30Ask a pharmacist about timing.
Other dopamine-raising or mood-altering supplements and herbs
other
Combinations are untested. The Reunion case notes toxicity may also follow combination with other psychoactive plants (as stated in the 2026 clinic review).Unknown.Authoritative guidance Very low certainty 7Avoid combining.
Who should check first 7
SituationAdviceEvidence
Taking levodopa, carbidopa or other Parkinson's medicine without your neurologist's agreementDo not self-add Mucuna.Authoritative guidance 7
Taking non-selective MAO inhibitorsAvoid (levodopa drug contraindication). (Inference: this is a levodopa-medicine label, not a Mucuna source.)Pharmacological theory 30
History of melanoma or suspicious undiagnosed skin lesionsAvoid (levodopa drug contraindication). (Inference: this is a levodopa-medicine label, not a Mucuna source.)Authoritative guidance 30 17
Narrow-angle glaucoma or severe psychosisAvoid (levodopa drug contraindications). (Inference: this is a levodopa-medicine label, not a Mucuna source.)Authoritative guidance 30
Pregnancy and breastfeedingAvoid; no Mucuna data, and rabbit malformations with levodopa drugs.Authoritative guidance 30 17
ChildrenNo Mucuna safety data were found; avoid.Authoritative guidance
Heart disease, low blood pressure, diabetes, psychiatric illnessMedical supervision needed; ask your doctor.Pharmacological theory 30 17
Overdose, product quality and regulators

Summary. The seed contains levodopa and possibly other active compounds. Raw seeds can cause vomiting, diarrhoea, confusion and hallucinations. The 2026 clinic review also describes a Mozambique outbreak (1989) linked to improper processing, with vomiting, diarrhoea, confusion and coma (secondary report, not read at source).

Animal. In mice, an ethanolic seed extract was relatively safe at low doses; adverse reactions appeared at 8 to 32 mg/kg with no deaths (rodent study).

Human doses studied. Single doses of seed powder and roasted powder daily up to 12 months in trials; amounts not given in all abstracts.

High dose or long term signals. Long-term overuse linked to dyskinesia and dopamine dysregulation (case reports). A review notes one patient who used Mucuna alone for two decades developed severe motor fluctuations needing deep brain stimulation (secondary report).

Overdose response. The Reunion Island patient recovered from nausea; the 2024 overuse case did not recover insight.

Genotoxicity. Not found.

Toxic plant parts. Raw seeds (levodopa and other compounds) and the hairs on pods and seeds (itch).

No contamination (metals, pesticides, microbes) testing of Mucuna products was found. The main quality problem is levodopa content.

Levodopa content varies from label. 6% to 141% of label claims in six products; none within 90 to 110%. 29

US label-database products. Levodopa in 15 of 16 products (2 to 241 mg per serving). Labels sometimes did not list levodopa; one sample per brand. 8

Natural variation and breakdown. Seeds ranged from 0.58% to 6.42% of dry weight; lab extraction tests showed about 52% degradation of L-dopa. 22

Multi-herb Ayurvedic products. Contents of mixed products were not studied in the sources read.

BodyActionDate
US Food and Drug Administration (United States)Mucuna is not formally approved or registered for Parkinson's by FDA or EMA; it is sold as a dietary supplement with limited oversight (2026 clinic review). source2026
NCCIH (US NIH) (United States)No NCCIH Mucuna pruriens page exists at the expected address (HTTP 404). Not found. source
When to get medical help
  • Hallucinations, paranoia, confusion or severe agitation after taking Mucuna.
  • Repeated vomiting or diarrhoea after eating seeds.
  • New uncontrolled movements, fainting, or very low blood pressure.
  • A new or changing mole or skin lesion.
  • Taking more Mucuna than planned or hiding use (possible dopamine dysregulation).

Stop the supplement and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.

General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.

Frequently asked questions

What is Mucuna pruriens?

Mucuna pruriens, or velvet bean, is a tropical legume. Its seeds naturally contain levodopa (L-DOPA), the main Parkinson's medicine. It is also sold online as a supplement.

9 7

Does Mucuna help Parkinson's disease?

Small trials found movement benefit similar to levodopa medicines. A 2025 review of five trials (108 people) rated three as low quality and called the evidence limited. It is not an approved treatment and has not been shown to slow the disease.

10 7

Is Mucuna safer than levodopa?

Not proven. Single-dose trials found fewer dyskinesias, but a 16-week pilot saw half of people stop, and overuse of supplements has caused psychosis and dyskinesia. Experts say it needs the same caution as levodopa medicines.

4 5 28 7

Can Mucuna boost testosterone or fertility?

Three uncontrolled studies from one Indian group report better sperm count and testosterone in infertile men. They had no placebo group, so the certainty is very low.

26 1 27

Does Mucuna reduce stress or help mood?

One uncontrolled study in stressed infertile men reported less stress. For depression there are animal studies only, and no human trial.

27 16

What are the side effects?

Nausea, dizziness and sleepiness are reported. Overuse has caused dyskinesia, hallucinations, paranoia and dopamine dysregulation. Raw seeds caused vomiting, diarrhoea, confusion and hallucinations.

7 28 14

Which medicines interact with Mucuna?

No Mucuna-specific interaction study was found. Based on levodopa drug labels: Parkinson's drugs, MAO inhibitors, antipsychotics and blood pressure medicines. A rat study suggests diabetes drugs could add to the effect. Ask your doctor or pharmacist.

30 17 15

Does L-DOPA in Mucuna raise melanoma risk?

Levodopa drug labels advise against use in people with a history of melanoma or suspicious skin lesions. No Mucuna-specific melanoma study was read, so this is a caution by inference.

30 17

Is Mucuna safe in pregnancy or breastfeeding?

No Mucuna data were found. Levodopa drugs caused malformations in rabbits, and carbidopa in milk is unknown. Avoid unless a doctor advises otherwise.

30

Why does the plant cause itching?

The hairs on the pods and seeds cause intense itching on skin contact. The case report on raw seeds mentions this, and researchers use Mucuna as an itch trigger in volunteers.

14 12

Do supplements contain what the label says?

Often not. Six products held 6% to 141% of their label levodopa, and 16 US products ranged from 2 to 241 mg per serving.

29 8

Is Mucuna approved or regulated?

Mucuna is not formally approved for Parkinson's by FDA or EMA and is sold as a supplement with limited oversight. We found no NCCIH page and no EMA/HMPC monograph; LiverTox could not be read.

7 18

Explore by health goal

Brain HealthMens VitalityFertility SupportStress ReductionMood BalanceHormone BalanceBlood Sugar BalanceLibido Support

Editorial transparency
Written by
AlternativeMed editorial team. Research compiled with AI assistance, then checked against PubMed records.
Medical review
None. This page has not been reviewed by a physician or pharmacist.
First published
2026-10-25
Last substantive update
2026-10-25
How we research
We searched PubMed, read abstracts of the trials and reviews, and read two reviews and a case report in full. Statements about drug interactions come from levodopa drug labels and are marked as inference. Pages that could not be opened are marked not read.
How we rate evidence
See "How we rate evidence" in the Evidence tab.
Independence
No product is promoted on this page. No affiliate links are shown.
Sources 30

Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.

  1. Ahmad MK, Mahdi AA, Shukla KK et al.. Effect of Mucuna pruriens on semen profile and biochemical parameters in seminal plasma of infertile men. Fertil Steril. 2008. PMID 18001713. DOI 10.1016/j.fertnstert.2007.07.1314. (abstract)
  2. Boonmongkol T, Phokaewvarangkul O, Vimolmangkang S et al.. Comparative efficacy of Mucuna pruriens and conventional levodopa in Parkinson's disease: a randomized controlled trial on pharmacokinetics and clinical perspectives from Asia. J Neural Transm (Vienna). 2025. PMID 40137945. DOI 10.1007/s00702-025-02914-2. (abstract)
  3. Caronni S, Del Sorbo F, Barichella M et al.. Mucuna pruriens to treat Parkinson's disease in low-income countries: Recommendations and practical guidelines from the farmer to clinical trials. Parkinsonism Relat Disord. 2024. PMID 38797572. DOI 10.1016/j.parkreldis.2024.106983. (abstract)
  4. Cilia R, Laguna J, Cassani E et al.. Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study. Neurology. 2017. PMID 28679598. DOI 10.1212/WNL.0000000000004175. (abstract)
  5. Cilia R, Laguna J, Cassani E et al.. Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study. Parkinsonism Relat Disord. 2018. PMID 29352722. DOI 10.1016/j.parkreldis.2018.01.014. (abstract)
  6. Cilia R, Cham M, Obese V et al.. Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial. J Parkinsons Dis. 2026. PMID 41269916. DOI 10.1177/1877718X251383721. (abstract)
  7. Cilia R, Katzenschlager R. "To Bean or Not to Bean": Therein lie the hype and the hope. Advice to people with Parkinson in my clinic about Mucuna pruriens. J Parkinsons Dis. 2026. PMID 42053204. DOI 10.1177/1877718X261442075. (full-text)
  8. Cohen PA, Avula B, Katragunta K, Khan I. Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database. JAMA Neurol. 2022. PMID 35939305. DOI 10.1001/jamaneurol.2022.2184. (full-text)
  9. GBIF. GBIF Backbone: Mucuna pruriens (L.) DC. (usageKey 2951499). GBIF. 2026. (full-text)
  10. Hammoud F, Ismail A, Zaher R et al.. Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials. Parkinsons Dis. 2025. PMID 40860042. DOI 10.1155/padi/1319419. (abstract)
  11. Katzenschlager R, Evans A, Manson A et al.. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004. PMID 15548480. DOI 10.1136/jnnp.2003.028761. (abstract)
  12. Lang-Illievich K, Klivinyi C, Schulze-Bauer H et al.. The effect of photobiomodulation on histamine and Mucuna pruriens-induced pruritus, hyperknesis and alloknesis in healthy volunteers: A double-blind, randomized, sham-controlled study. PLoS One. 2024. PMID 39024251. DOI 10.1371/journal.pone.0307034. (abstract)
  13. Lieu CA, Venkiteswaran K, Gilmour TP et al.. The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate. Evid Based Complement Alternat Med. 2012. PMID 22997535. DOI 10.1155/2012/840247. (abstract)
  14. Maillot A, Schmitt C, Marteau A. Poisoning After Ingestion of Mucuna pruriens Seeds on Reunion Island. Wilderness Environ Med. 2022. PMID 34895813. DOI 10.1016/j.wem.2021.10.004. (abstract)
  15. Majekodunmi SO, Oyagbemi AA, Umukoro S, Odeku OA. Evaluation of the anti-diabetic properties of Mucuna pruriens seed extract. Asian Pac J Trop Med. 2011. PMID 21914541. DOI 10.1016/S1995-7645(11)60161-2. (abstract)
  16. Mata-Bermudez A, Diaz-Ruiz A, Silva-Garcia LR et al.. Mucuna pruriens, a Possible Treatment for Depressive Disorders. Neurol Int. 2024. PMID 39585071. DOI 10.3390/neurolint16060112. (abstract)
  17. MedlinePlus (US National Library of Medicine). Carbidopa and Levodopa (patient drug information). MedlinePlus (US National Library of Medicine). 2024. (full-text)
  18. NCCIH. NCCIH: no Mucuna pruriens page (HTTP 404 at /health/mucuna-pruriens). NCCIH. 2026. (summary-only)
  19. PubChem. PubChem: Levodopa (CID 6047). PubChem. 2026. (summary-only)
  20. PubChem. PubChem: Serotonin (CID 5202). PubChem. 2026. (summary-only)
  21. PubChem. PubChem: 5-Hydroxytryptophan (CID 144). PubChem. 2026. (summary-only)
  22. Pulikkalpura H, Kurup R, Mathew PJ, Baby S. Levodopa in Mucuna pruriens and its degradation. Sci Rep. 2015. PMID 26058043. DOI 10.1038/srep11078. (abstract)
  23. Radder DLM, Tiel Groenestege AT, Boers I et al.. Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report. J Parkinsons Dis. 2019. PMID 30856121. DOI 10.3233/JPD-181500. (abstract)
  24. Roozbeh N, Amirian A, Abdi F et al.. A Systematic Review on Use of Medicinal Plants for Male Infertility Treatment. J Family Reprod Health. 2021. PMID 34721595. DOI 10.18502/jfrh.v15i2.6447. (abstract)
  25. Sakata M, Miyamoto K, Koh J et al.. Japanese Mucuna pruriens (Hasshou Beans) Showed Fast-acting and Long-lasting Effects in Parkinson's Disease. Intern Med. 2024. PMID 38462520. DOI 10.2169/internalmedicine.3171-23. (abstract)
  26. Shukla KK, Mahdi AA, Ahmad MK et al.. Mucuna pruriens improves male fertility by its action on the hypothalamus-pituitary-gonadal axis. Fertil Steril. 2009. PMID 18973898. DOI 10.1016/j.fertnstert.2008.09.045. (abstract)
  27. Shukla KK, Mahdi AA, Ahmad MK et al.. Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men. Evid Based Complement Alternat Med. 2010. PMID 18955292. DOI 10.1093/ecam/nem171. (abstract)
  28. Sohutskay DO, Suen RM, Ali F et al.. Dopamine Dysregulation Syndrome Presenting as Overuse of Mucuna pruriens Levodopa Supplement. J Mov Disord. 2024. PMID 38768952. DOI 10.14802/jmd.24067. (full-text)
  29. Soumyanath A, Denne T, Hiller A et al.. Analysis of Levodopa Content in Commercial Mucuna pruriens Products Using High-Performance Liquid Chromatography with Fluorescence Detection. J Altern Complement Med. 2018. PMID 28922612. DOI 10.1089/acm.2017.0054. (abstract)
  30. UK electronic Medicines Compendium. SINEMET 12.5 mg/50 mg Tablets: Summary of Product Characteristics (levodopa/carbidopa drug label). UK electronic Medicines Compendium. 2024. (full-text)

Where to buy

Check the label first. Whatever you buy, look for these:

  • The plant part and the extract type or ratio on the label
  • A standardized amount of the active compounds, where relevant
  • A third-party testing mark (USP, NSF or ConsumerLab)
  • Interactions: ask a pharmacist if you take medicines, are pregnant or have a medical condition

Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.

Browse Mucuna Pruriens on Amazon
Amazon · Several brands to compare
Shop Mucuna Pruriens on Amazon

Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.

Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.